Skip to main content
Back to News

News From Around the System

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

UC San Diego Health — May 15, 2020

The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A QandA with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.

UCI Health to test drug for critically ill COVID-19 patients

UCI Health — May 12, 2020

Orange, Calif. — UCI Health is initiating a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history…

Tu Foundation gives $2.5 million for COVID-19 patient care, research

UCI Health — May 10, 2020

Irvine, Calif. — A $2.5-million gift from the John and Mary Tu Foundation to the University of California, Irvine is supporting COVID-19-associated patient care at UCI Health and to advance clinical and translational research across the university campus that is focused on new ways to test for and treat the…

Introducing the UC San Diego Return to Learn Program

UC San Diego Health — May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts